Announced Wed, 8 Jul · 16:51 IST
Board approves Rs 249 cr equity allotment and Singapore WOS incorporation
Strategic Transactions View source PDF
SUVEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+12.1%1-day move
₹318.00
prior close
₹320.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0+1.5+1.6+2.0+12.1+12.9+9.7+12.4+7.2+6.3————
Up moveDown movePending
AI summary
Board approved three items July 8: 1) Allotment of 1.85 crore shares to 17 non-promoter entities at Rs 134 each via warrant conversion, raising about Rs 248.84 crore. Paid-up capital rises to Rs 28.26 crore. 2) Re-appointment of Dr. Vajja Sambasiva Rao as Independent Director for 5 years. 3) Incorporation of wholly owned subsidiary Suven Neurosciences Pte. Ltd. in Singapore for biopharma work on neurological disorders, with up to USD 100 mn planned investment.
Likely market impact
Capital raised via warrant conversion; Singapore WOS extends business into clinical biopharma. Share count rises about 7 percent on allotment.